RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-97d54a1cf24a7baaGRADE VERY_LOW
salmon constituents — inflammation
direction BENEFIT · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
LOWnumeric
4bound studies
Bound studies (4 shown of 4)
STU-29aca75781b6735fANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-82dc36768e14cebdRCT · HUMAN · 2026 · RoB SOME_CONCERNS
5 endpoints
STU-a2db61f4b5f6b07eANIMAL · ANIMAL · 2026 · RoB INSUFFICIENT_INFORMATION
5 endpoints
STU-e681246c55e54e21IN_VITRO · IN_VITRO · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
Opposition screen
SCREEN · 8 candidates considered · 3 bound as opposing
SYNTHESIS SYN-e81b5da2fd1aab — outcome QUALITATIVE_ONLY · BENEFIT ×4 · not_assessed_quantitatively · 4 members
PROVENANCE → epmc:40607398, epmc:42652046, epmc:41898665 · PKG e84df135bd1a1bfd…
CLAIM · CLM-6c47da7d4e17ce84GRADE VERY_LOW
salmon — inflammation
direction NULL · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
LOWnumeric
2bound studies
Bound studies (2 shown of 2)
STU-1ec2e8ecf470af0aANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
6 endpoints
STU-b580e339444f2746UNSPECIFIED · HUMAN · 2026 · RoB NOT_ASSESSABLE
1 endpoints
Quantitative observations
Opposition screen
SCREEN · 8 candidates considered · 3 bound as opposing
SYNTHESIS SYN-e2285b4aa912e4 — outcome QUALITATIVE_ONLY · UNCERTAIN ×2 · not_assessed_quantitatively · 2 members
PROVENANCE → epmc:41334221, epmc:42763505 · PKG e84df135bd1a1bfd…
Bounded preview — representative records only. The full release ships 17 claims and 39 observations.